Insulin Resistance Test (75g) in Lahore at Chughtai Lab

Insulin Resistance Test (After 75 Grams Glucose) at Chughtai Lab

The Insulin Resistance Test (After 75 Grams Glucose), also clinically recognized as the Oral Glucose Tolerance Test (OGTT) with parallel Insulin measurements, is a sophisticated diagnostic evaluation designed to assess how efficiently the human body metabolizes carbohydrates. Unlike a simple fasting blood sugar test, which only provides a static snapshot of glucose levels, this dynamic test evaluates the functional relationship between blood glucose and the pancreatic hormone insulin under a standardized physiological challenge. By introducing a precise 75-gram load of anhydrous glucose, clinicians can observe the real-time response of the pancreas and peripheral tissues, making it an invaluable tool for detecting early-stage metabolic dysfunction before it progresses to irreversible clinical conditions.

At Chughtai Lab, Pakistan’s premier diagnostic institution, this test is performed using state-of-the-art automated chemiluminescence immunoassay (CLIA) technology for insulin determination, alongside highly accurate enzymatic hexokinase methods for plasma glucose measurement. The primary anatomical and physiological systems evaluated during this test include the endocrine pancreas—specifically the insulin-secreting beta cells of the Islets of Langerhans—and peripheral insulin-sensitive tissues, including skeletal muscle, adipose tissue, and the liver. Understanding this metabolic interplay is crucial because insulin resistance is the pathophysiological cornerstone of type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), and various reproductive disorders such as Polycystic Ovary Syndrome (PCOS).

The diagnostic value of this test lies in its ability to identify “silent” metabolic abnormalities. In the early stages of insulin resistance, fasting blood glucose levels often remain entirely normal because the pancreas compensates by secreting excessively high amounts of insulin (compensatory hyperinsulinemia). Standard screening tests like HbA1c or fasting glucose may fail to detect this underlying strain on the pancreas. By measuring both glucose and insulin levels at fasting and two hours after a 75-gram glucose challenge, Chughtai Lab provides clinicians with the precise data required to calculate insulin sensitivity indices, such as the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and the Quantitative Insulin Sensitivity Check Index (QUICKI), allowing for timely, preventative therapeutic interventions.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy and reproducibility of the test results, patients must strictly adhere to the following preparation guidelines prior to visiting Chughtai Lab:

• Nutritional Stability: Maintain a unrestricted diet containing at least 150 grams of carbohydrates per day for three days prior to the test. Restricting carbohydrates before the test can lead to false-positive results (artificial glucose intolerance).
• Overnight Fasting: Observe a strict overnight fast of 8 to 12 hours. During this fasting window, only plain water is permitted. Avoid tea, coffee, smoking, chewing gum, or any form of caloric intake.
• Medication Management: Consult your prescribing physician regarding any medications that may influence glucose metabolism, such as corticosteroids, oral contraceptives, diuretics, metformin, or other anti-diabetic agents. Do not alter your medication schedule without explicit medical advice.
• Physical Rest: Avoid strenuous physical exercise or heavy exertion for 24 hours before the test, as acute exercise temporarily enhances insulin sensitivity and can skew the baseline measurements.
• Avoid Stress: Arrive at the laboratory in a calm, relaxed state, as physiological stress triggers the release of cortisol and epinephrine, both of which elevate blood glucose levels.

During the Procedure

The Insulin Resistance Test is a multi-step process that requires the patient to remain at the Chughtai Lab facility for approximately two to three hours. The clinical sequence is as follows:

• Baseline Venipuncture: Upon arrival, a phlebotomist will perform a baseline blood draw from a vein in your arm to measure fasting plasma glucose and fasting insulin levels.
• Glucose Ingestion: You will be given a standardized drink containing exactly 75 grams of anhydrous glucose dissolved in approximately 250 to 300 ml of water. This sweet solution must be consumed entirely within a 5-minute window.
• Resting Period: After consuming the glucose drink, you must remain seated quietly in the waiting area. Walking around, smoking, eating, or drinking other fluids is strictly prohibited during the test, as physical activity will artificially lower blood glucose levels.
• Post-Load Venipuncture: Exactly 120 minutes (two hours) after completing the glucose drink, a second blood sample will be drawn to measure post-load plasma glucose and post-load insulin levels. In some clinical protocols, an additional draw at the 60-minute mark may also be requested by your physician.
• Patient Experience and Safety: The glucose drink is highly concentrated and sweet, which may occasionally cause mild nausea, abdominal discomfort, or lightheadedness in sensitive individuals. Our trained laboratory staff are always on hand to assist you should you feel unwell during the observation period.

When is an Insulin Resistance Test (After 75 Grams Glucose) Performed?

Evaluation of Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome is a highly prevalent endocrine disorder in women of reproductive age, characterized by ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology. Insulin resistance is a core pathophysiological driver of PCOS, present in both lean and obese patients. High circulating insulin levels stimulate the ovarian theca cells to produce excess androgens, leading to symptoms like hirsutism, severe acne, and irregular menstrual cycles. Physicians request this test to quantify metabolic dysfunction in PCOS patients, helping to guide targeted therapies such as insulin sensitizers (metformin) and personalized dietary interventions.

Assessment of Metabolic Syndrome and Cardiovascular Risk

Metabolic Syndrome is a cluster of conditions—including abdominal obesity, elevated blood pressure, high triglycerides, low HDL cholesterol, and borderline glucose levels—that collectively increase the risk of coronary artery disease, stroke, and type 2 diabetes. Insulin resistance is the unifying mechanism behind these metabolic abnormalities. By performing the 75-gram glucose challenge with insulin tracking, clinicians can identify patients who are at high risk of cardiovascular events, enabling aggressive lifestyle modifications and medical therapies to prevent long-term vascular damage.

Screening for Prediabetes and Early Type 2 Diabetes

When routine screening tests like fasting blood glucose or HbA1c yield borderline or ambiguous results, the 75-gram glucose challenge serves as a definitive diagnostic tool. It evaluates the body’s dynamic glucose clearance capacity. If the pancreas is struggling to produce enough insulin to clear the 75-gram glucose load, or if the peripheral tissues are highly resistant to the insulin produced, this test will clearly demonstrate impaired glucose tolerance (IGT) or early-stage type 2 diabetes, allowing for immediate clinical intervention.

Investigation of Unexplained Weight Gain and Metabolic Obesity

Many patients experience progressive weight gain, particularly around the abdomen (visceral adiposity), and find it exceptionally difficult to lose weight despite caloric restriction and exercise. Chronic hyperinsulinemia, a direct consequence of insulin resistance, acts as a potent biochemical block against lipolysis (the breakdown of stored fat) while actively promoting lipogenesis (fat storage). This test helps physicians determine if an underlying metabolic block is preventing weight loss, shifting the treatment focus from simple caloric restriction to metabolic restoration.

Evaluation of Acanthosis Nigricans and Dermatological Markers

Acanthosis nigricans is a dermatological condition characterized by dark, velvety, hyperpigmented patches of skin, typically located in intertriginous areas such as the neck, axillae, and groin. This skin change, often accompanied by multiple skin tags (acrochordons), is a direct physical manifestation of severe insulin resistance. High levels of circulating insulin cross-react with insulin-like growth factor-1 (IGF-1) receptors on keratinocytes and fibroblasts, causing them to proliferate. When these physical signs are present, physicians order the insulin resistance test to confirm the metabolic diagnosis and assess its severity.

What Does an Insulin Resistance Test (After 75 Grams Glucose) Detect?

This comprehensive metabolic evaluation is capable of detecting a wide array of physiological states, clinical conditions, and metabolic abnormalities, including:

• Optimal Insulin Sensitivity: Normal fasting and post-load glucose and insulin levels, indicating highly efficient cellular response to insulin.
• Compensatory Hyperinsulinemia: Elevated fasting or post-load insulin levels paired with completely normal glucose levels, showing the pancreas is overworking to maintain glucose balance.
• Impaired Fasting Glucose (IFG): Fasting plasma glucose levels between 100 and 125 mg/dL, indicating early hepatic insulin resistance.
• Impaired Glucose Tolerance (IGT): Two-hour post-load glucose levels between 140 and 199 mg/dL, indicating peripheral muscle insulin resistance.
• Overt Type 2 Diabetes Mellitus: Fasting glucose ≥ 126 mg/dL or 2-hour post-load glucose ≥ 200 mg/dL.
• Severe Insulin Resistance: Marked elevations in both glucose and insulin levels at the 2-hour mark, indicating advanced receptor desensitization.
• Pancreatic Beta-Cell Exhaustion: Elevated glucose levels accompanied by abnormally low or flat insulin responses, indicating pancreatic fatigue.
• Reactive Hypoglycemia: A rapid drop in blood glucose below 70 mg/dL at the 2-hour mark, driven by an excessive, delayed spike in insulin secretion.
• Elevated HOMA-IR Index: A calculated value indicating significant resistance to insulin at the hepatic level.
• Suppressed QUICKI Index: A mathematical index indicating reduced overall insulin sensitivity.
• Visceral Adiposity-Driven Metabolic Strain: Metabolic patterns characteristic of high visceral fat accumulation.
• PCOS-Associated Insulin Resistance: Specific patterns of hyperinsulinemia that correlate with ovarian androgen excess.
• Subclinical Metabolic Syndrome: Early-stage metabolic dysfunction before the full clinical syndrome manifests.
• Hepatic Insulin Resistance: Specifically characterized by elevated fasting glucose due to uncontrolled gluconeogenesis.
• Peripheral Tissue Insulin Resistance: Characterized by delayed clearance of glucose at the 2-hour mark.
• Gestational Diabetes Risk: Early metabolic indicators of potential glucose intolerance during pregnancy.
• Acanthosis Nigricans Correlation: Laboratory confirmation of the metabolic driver behind hyperpigmented skin patches.
• Cardiovascular Risk Stratification: Identification of atherogenic metabolic profiles associated with high insulin levels.
• Dysmetabolic Hyperferritinemia Association: Metabolic patterns often linked with unexplained elevations in serum ferritin.
• Early-Stage Beta-Cell Dysfunction: Subtle delays in the first-phase insulin response following glucose ingestion.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is dedicated to providing rapid, highly accurate, and easily accessible diagnostic results. For the Insulin Resistance Test (After 75 Grams Glucose), the standard turnaround time is typically within 12 to 24 hours from the time of sample collection. Because this test involves multiple precise assays (both glucose and insulin at multiple time points), our clinical chemistry department conducts rigorous quality control checks before releasing the final report.

Patients can access their reports seamlessly through multiple digital channels. Once the report is finalized and signed off by a Consultant Pathologist, an automated SMS notification containing a direct download link is sent to the patient’s registered mobile number. Reports can also be viewed, downloaded, and printed via the official Chughtai Lab online portal or the user-friendly Chughtai Healthcare mobile application. For patients who prefer physical copies, reports can be collected from any of our conveniently located collection centers across Pakistan.

Insulin Resistance Test Findings Overview

The following table outlines the typical parameters evaluated during the Insulin Resistance Test, along with their normal and potential abnormal clinical interpretations:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Fasting Plasma Glucose	70 – 99 mg/dL	100 – 125 mg/dL (Impaired Fasting Glucose); ≥ 126 mg/dL (Diabetes)
Fasting Insulin	2.0 – 10.0 mIU/L (Optimal)	> 15.0 mIU/L (Fasting Hyperinsulinemia / Insulin Resistance)
2-Hour Post-Load Glucose	< 140 mg/dL	140 – 199 mg/dL (Impaired Glucose Tolerance); ≥ 200 mg/dL (Diabetes)
2-Hour Post-Load Insulin	< 45.0 mIU/L	> 80.0 mIU/L (Post-Load Hyperinsulinemia / Severe Resistance)
HOMA-IR Index	< 1.0 (Optimal); < 1.9 (Normal)	> 1.9 (Early Insulin Resistance); > 2.9 (Significant Insulin Resistance)
QUICKI Index	> 0.382 (Optimal)	< 0.339 (Decreased Insulin Sensitivity)
Insulin-to-Glucose Ratio	< 0.3 (Fasting)	> 0.4 (Indicative of underlying insulin resistance)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Insulin Resistance Test?

• ISO 15189 Certified Laboratories: Chughtai Lab adheres to international quality standards, ensuring the highest level of accuracy and reliability in clinical testing.
• Advanced Automated Analyzers: We utilize state-of-the-art, fully automated chemiluminescence and clinical chemistry platforms to minimize human error.
• Expert Pathologist Oversight: Every complex metabolic report is reviewed and signed off by highly qualified Consultant Pathologists.
• Convenient Home Sample Collection: Patients can book our professional home sampling service, allowing the multi-step test to be conducted in the comfort of their home.
• Seamless Digital Access: Access your reports instantly via our mobile app, online portal, or automated WhatsApp service.
• Strict Cold Chain Maintenance: We ensure rigorous temperature-controlled transport of all blood samples to preserve delicate hormones like insulin.
• Extensive Nationwide Network: With hundreds of collection centers across Pakistan, finding a Chughtai Lab branch near you is simple and convenient.
• Patient-Centric Care: Our compassionate, highly trained phlebotomists and support staff ensure a comfortable and professional testing experience.